Immune to Cancer: The CRI Blog
-
The IO Clinical Trial Gap in the Black Patient Population: It’s Time to Sound the Alarm
In 2017, I was diagnosed with stage four triple-negative breast cancer (TNBC), one of the most aggressive… -
Celebrating Seven Decades of CRI Discovery in Cancer Immunotherapy
On January 27, 1953, the Cancer Research Institute’s founders, Helen Coley Nauts and Oliver R. Grace Sr.,… -
Five Cancer Research Institute Scientists Recognized with Career Awards by The American Association of Immunologists
Five CRI-supported scientists were honored with AAI Career Awards Coinciding with the 70th anniversary of the founding… -
5 Things Patients, Caregivers, and Families Need to Know About Cancer
Our CEO speaks with Medium/Authority Magazine about cancer, immunotherapy, and how she became CEO of the world’s… -
Engineering Better CAR T Cells with CRI Lloyd J. Old STAR Yvonne Chen
CRI STAR Yvonne Chen is exploring several strategies to improve the safety and effectiveness of CAR T… -
2022 International Cancer Immunotherapy Conference Highlights from Day 4
The final day of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22) wrapped up an amazing conference… -
2022 International Cancer Immunotherapy Conference Highlights from Day 3
The third day of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22) focused on two relatively new… -
2022 International Cancer Immunotherapy Conference Highlights from Day 2
The second day of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22) started off by delving deeper… -
2022 International Cancer Immunotherapy Conference Highlights from Day 1
Back for the first time since the COVID-19 pandemic began, the sixth annual CRI-ENCI-AACR International Cancer Immunotherapy…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.